These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4665550)

  • 1. [Significance of enzyme activity in pyrimidine biosynthesis for the development of galactosamine liver lesions].
    Pausch J; Keppler D; Decker K
    Verh Dtsch Ges Inn Med; 1972; 78():1375-7. PubMed ID: 4665550
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of tyrosine aminotransferase in galactosamine hepatitis.
    Pugge HR; Torrecilla A; Pellanda RJ
    Acta Gastroenterol Latinoam; 1979; 9(3):159-63. PubMed ID: 43646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-galactosamine and acute liver cell injury.
    Shinozuka H; Farber JL; Konishi Y; Anukarahanonta T
    Fed Proc; 1973 Apr; 32(4):1516-26. PubMed ID: 4701754
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the mechanism of galactosamine-induced hepatitis].
    Keppler D; Reutter W; Lesch R; Decker K
    Verh Dtsch Ges Inn Med; 1969; 75():361-3. PubMed ID: 5400153
    [No Abstract]   [Full Text] [Related]  

  • 5. Dysregulation of protein synthesis in injured liver. A comparative study on microsomal and cytosole enzyme activities, microsomal lipoperoxidation and polysomal pattern in D-galactosamine and carbon tetrachloride-injured livers.
    Watanabe A; Akamatsu K; Takesue A; Taketa K
    Enzyme; 1978; 23(5):320-7. PubMed ID: 710383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of essential phospholipids on the galactosamine hepatitis in rats].
    Petzold H; Titlbach O
    Cesk Gastroenterol Vyz; 1974 Apr; 28(3):178-80. PubMed ID: 4447983
    [No Abstract]   [Full Text] [Related]  

  • 7. [Function of lysosomal enzymes in galactosamine hepatitis].
    Heissmeyer H; Stein U
    Verh Dtsch Ges Inn Med; 1972; 78():1377-80. PubMed ID: 4665551
    [No Abstract]   [Full Text] [Related]  

  • 8. [Favorable action of preliminary fasting on changes in liver plasma membrane enzymes due to the use of D-galactosamine].
    Adzharov D; Dimov S; Savov G; Naĭdenova E; Petrova S
    Eksp Med Morfol; 1987; 26(2):20-3. PubMed ID: 3608898
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of fasting on galactosamine induced hepatitis in experimental animals.
    Pickering RW
    Arzneimittelforschung; 1977; 27(10):1992-6. PubMed ID: 579109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of azathioprine and phenobarbital on acute liver damage produced by galactosamine.
    Perings E; Brunner G; Vido I; Söling HD; Creutzfeldt W
    Acta Hepatogastroenterol (Stuttg); 1973; 20(2):130-4. PubMed ID: 4148023
    [No Abstract]   [Full Text] [Related]  

  • 11. [Primary and secondary liver response to D-galactosamine administration in galactosamine hepatitis].
    Reutter W; Bauer C; Bachman W; Lesch R
    Verh Dtsch Ges Inn Med; 1973; 79():927-30. PubMed ID: 4790045
    [No Abstract]   [Full Text] [Related]  

  • 12. [Incorporation of 14-C-Glycine during galactosamine hepatitis of young and old rats (author's transl)a*].
    Platt D; Förster L; Förster K
    Aktuelle Gerontol; 1976 Jul; 6(7):319-27. PubMed ID: 14537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possibilities of liver damage by foreign substances].
    Bien E
    Pharmazie; 1985 Nov; 40(11):815-20. PubMed ID: 3938023
    [No Abstract]   [Full Text] [Related]  

  • 14. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death.
    Decker K; Keppler D
    Rev Physiol Biochem Pharmacol; 1974; (71):77-106. PubMed ID: 4375846
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lipid metabolism and liver function in D-galactosamine poisoning in rats].
    Vengerovskiĭ AI; Saratikov AS
    Patol Fiziol Eksp Ter; 1988; (3):52-5. PubMed ID: 3174253
    [No Abstract]   [Full Text] [Related]  

  • 16. [Galactosamine hepatitis: injury to the plasma membrane of hepatic cells following administration of D-galactosamine].
    Reutter W; Bachmann W
    Verh Dtsch Ges Inn Med; 1971; 77():1177-8. PubMed ID: 5155984
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of uridine diphosphoglucose dehydrogenase by galactosamine-I-phosphate and UDP-galactosamine.
    Bauer C; Reutter W
    Biochim Biophys Acta; 1973 Jan; 293(1):11-4. PubMed ID: 4734370
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relations between phospholipid composition of plasma and liver microsomes in experimental cholestasis and hepatitis].
    Gallenkamp H; Brachtel D; Richter E
    Verh Dtsch Ges Inn Med; 1973; 79():930-3. PubMed ID: 4790046
    [No Abstract]   [Full Text] [Related]  

  • 19. Galactosamine induced liver injury.
    Decker K; Keppler D
    Prog Liver Dis; 1972; 4():183-99. PubMed ID: 4631501
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition, by drugs, of galactosamine induced hepatitis in the rat.
    Pickering RW; Lynn James GW; Parker FL
    Arzneimittelforschung; 1975 Oct; 25(10):1591-2. PubMed ID: 1243044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.